{
  "paper": {
    "title": "SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade",
    "doi": "10.1038/s41586-025-09006-8",
    "publication_year": 2025,
    "domain": "oncology-immunology",
    "study_type": "preclinical+retrospective"
  },
  "core_question": "Can intratumoral mRNA vaccination sensitize tumors to immune checkpoint blockade and improve outcomes with anti‑PD‑L1 therapy?",
  "datasets_or_cohorts": [
    {
      "id": "mouse-efficacy",
      "label": "Mouse efficacy cohort",
      "sample_size_or_observations": "78 mice",
      "description": "Combination therapy of intratumoral mRNA vaccine with anti‑PD‑L1 in 78 tumor‑bearing mice pooled across experiments."
    },
    {
      "id": "mouse-control",
      "label": "Mouse control cohort",
      "sample_size_or_observations": "84 mice",
      "description": "Control groups including vaccine‑only, ICI‑only, and vehicle in 84 tumor‑bearing mice pooled across matched controls."
    },
    {
      "id": "human-retrospective",
      "label": "Human retrospective metastatic cohort",
      "sample_size_or_observations": "130 patients",
      "description": "Metastatic cancer patients treated with ICI, stratified by prior SARS‑CoV‑2 mRNA vaccination status."
    },
    {
      "id": "human-vaccinated",
      "label": "Vaccinated subgroup",
      "sample_size_or_observations": "43 patients",
      "description": "Subset of the retrospective cohort who had received a SARS‑CoV‑2 mRNA vaccine prior to ICI therapy."
    },
    {
      "id": "human-unvaccinated",
      "label": "Unvaccinated subgroup",
      "sample_size_or_observations": "87 patients",
      "description": "Subset of the retrospective cohort without prior SARS‑CoV‑2 mRNA vaccination."
    }
  ],
  "major_limitations": [
    "The human analysis is retrospective and non‑randomized, introducing potential confounding.",
    "Vaccination timing relative to ICI initiation varied among patients, affecting comparability.",
    "Mouse model findings may not fully translate to diverse human tumor types and treatment histories."
  ]
}